{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:56:05Z","timestamp":1790812565449,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T00:00:00Z","timestamp":1750809600000},"content-version":"vor","delay-in-days":85,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.vaccine.2025.126765","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T04:33:00Z","timestamp":1741581180000},"page":"126765","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Childhood invasive pneumococcal disease and acute otitis media in Central Greece during 2005-2024 \u2013 A report at the doorstep of the new multivalent PCV era"],"prefix":"10.1016","volume":"52","author":[{"given":"George A.","family":"Syrogiannopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aspasia N.","family":"Michoula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Moriondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Nieddu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theoni G.","family":"Syrogiannopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B.","family":"Anthracopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efthymia","family":"Petinaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Azzari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioanna N.","family":"Grivea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vaccine.2025.126765_bb0005","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.idc.2015.07.009","article-title":"Pneumococcal disease in the era of pneumococcal conjugate vaccine","volume":"29","author":"Yildirim","year":"2015","journal-title":"Infect Dis Clin N Am"},{"issue":"5","key":"10.1016\/j.vaccine.2025.126765_bb0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177113","article-title":"Serotype distribution of Streptococcus pneumoniae causing invasive disease in children in the post-PCV era: a systematic review and meta-analysis","volume":"12","author":"Balsells","year":"2017","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.vaccine.2025.126765_bb0015","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1093\/cid\/ciaa917","article-title":"Invasive disease potential of pneumococcal serotypes in children after PCV13 implementation","volume":"72","author":"Cohen","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126765_bb0020","doi-asserted-by":"crossref","first-page":"24534","DOI":"10.1038\/s41598-021-03720-y","article-title":"Molecular surveillance of pneumococcal carriage following completion of immunization with the 13-valent pneumococcal conjugate vaccine administered in a 3+1 schedule","volume":"11","author":"Syrogiannopoulos","year":"2021","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126765_bb0025","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3201\/eid2801.210734","article-title":"SpIDnet group. Serotype replacement after introduction of 10-valent and 13-valent pneumococcal conjugate vaccines in 10 countries, Europe","volume":"28","author":"Hanquet","year":"2022","journal-title":"Emerg Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2025.126765_bb0030","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1093\/cid\/ciab645","volume":"74","author":"Ben-Shimol","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2025.126765_bb0035","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ijregi.2023.05.005","article-title":"Pneumococcal colonization and severity of pneumonia in hospitalized Cambodian children following introduction of the 13-valent pneumococcal conjugate vaccine","volume":"8","author":"Miliya","year":"2023","journal-title":"IJID Reg"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126765_bb0040","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2023-063039","article-title":"Invasive pneumococcal disease after 2 decades of pneumococcal conjugate vaccine use","volume":"153","author":"Yildirim","year":"2024","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.vaccine.2025.126765_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0211712","article-title":"Bacterial causes of otitis media with spontaneous perforation of the tympanic membrane in the era of 13 valent pneumococcal conjugate vaccine","volume":"14","author":"Levy","year":"2019","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.vaccine.2025.126765_bb0050","article-title":"Otorrhea bacterial profile, epidemiology before widespread use of the third-generation pneumococcal conjugate vaccine in French children, a prospective study from 2015 to 2023","volume":"53","author":"Levy","year":"2023","journal-title":"Infect Dis Now"},{"issue":"10","key":"10.1016\/j.vaccine.2025.126765_bb0055","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1097\/INF.0000000000004413","article-title":"Anticipated effects of higher-valency pneumococcal conjugate vaccines on colonization and acute otitis media","volume":"43","author":"Kaur","year":"2024","journal-title":"Pediatr Infect Dis J"},{"issue":"8","key":"10.1016\/j.vaccine.2025.126765_bb0060","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1017\/S0950268813002744","article-title":"Incidence and clinical presentation of acute otitis media in children aged <6 years in European medical practices","volume":"142","author":"Liese","year":"2014","journal-title":"Epidemiol Infect"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126765_bb0065","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10096-016-2783-9","article-title":"Acute otitis media with spontaneous tympanic membrane perforation","volume":"36","author":"Principi","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2025.126765_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009282","article-title":"Realtime PCR is more sensitive than multiplex PCR for diagnosis and serotyping in children with culture negative pneumococcal invasive disease","volume":"5","author":"Azzari","year":"2010","journal-title":"PLoS One"},{"issue":"16","key":"10.1016\/j.vaccine.2025.126765_bb0075","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1016\/j.vaccine.2011.12.008","article-title":"Italian group for the study of invasive pneumococcal disease. Potential serotype coverage of three pneumococcal conjugate vaccines against invasive pneumococcal infection in Italian children","volume":"30","author":"Azzari","year":"2012","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2025.126765_bb0080","doi-asserted-by":"crossref","first-page":"e3778","DOI":"10.1093\/cid\/ciaa1483","article-title":"Nationwide trends of invasive pneumococcal disease in Spain from 2009 through 2019 in children and adults during the pneumococcal conjugate vaccine era","volume":"73","author":"de Miguel","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2025.126765_bb0085","doi-asserted-by":"crossref","DOI":"10.1128\/Spectrum.01150-21","article-title":"Catalan study group of invasive pneumococcal disease. Serotypes and clonal composition of Streptococcus pneumoniae isolates causing IPD in children and adults in Catalonia before 2013 to 2015 and after 2017 to 2019 systematic introduction of PCV13","volume":"9","author":"Redin","year":"2021","journal-title":"Microbiol Spectr"},{"issue":"7","key":"10.1016\/j.vaccine.2025.126765_bb0090","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.3390\/microorganisms9071428","volume":"9","author":"Silva-Costa","year":"2021","journal-title":"Microorganisms"},{"issue":"5","key":"10.1016\/j.vaccine.2025.126765_bb0095","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S1473-3099(23)00706-5","article-title":"Invasive pneumococcal disease 3 years after introduction of a reduced 1 + 1 infant 13-valent pneumococcal conjugate vaccine immunisation schedule in England: a prospective national observational surveillance study","volume":"24","author":"Bertran","year":"2024","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2025.126765_bb0100","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1080\/23744235.2016.1192720","article-title":"Pneumonia with empyema among children in the first five years of high coverage with 13-valent pneumococcal conjugate vaccine","volume":"48","author":"Syrogiannopoulos","year":"2016","journal-title":"Infect Dis (Lond)"},{"issue":"7","key":"10.1016\/j.vaccine.2025.126765_bb0105","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.3201\/eid2407.180029","volume":"24","author":"Silva-Costa","year":"2018","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2025.126765_bb0110","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/thoraxjnl-2020-216032","article-title":"Assessing the impact of the 13 valent pneumococcal vaccine on childhood empyema in Australia","volume":"76","author":"Strachan","year":"2021","journal-title":"Thorax"},{"issue":"48","key":"10.1016\/j.vaccine.2025.126765_bb0115","doi-asserted-by":"crossref","first-page":"8882","DOI":"10.1016\/j.vaccine.2011.09.074","article-title":"Dynamics of Streptococcus pneumoniae nasopharyngeal carriage with high heptavalent pneumococcal conjugate vaccine coverage in Central Greece","volume":"29","author":"Grivea","year":"2011","journal-title":"Vaccine"},{"issue":"48","key":"10.1016\/j.vaccine.2025.126765_bb0120","doi-asserted-by":"crossref","first-page":"6513","DOI":"10.1016\/j.vaccine.2014.09.016","article-title":"Dynamics of pneumococcal carriage among day-care center attendees during the transition from the 7-valent to the higher-valent pneumococcal conjugate vaccines in Greece","volume":"32","author":"Grivea","year":"2014","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2025.126765_bb0125","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2022.2079923","article-title":"The EGNATIA Study Group. Pneumococcal serotypes in adults hospitalized with community-acquired pneumonia in Greece using urinary antigen detection tests: the EGNATIA study, November 2017\u2013April 2019","volume":"18","author":"Liapikou","year":"2022","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2025.126765_bb0130","article-title":"The Pserenade team. Serotype distribution of remaining pneumococcal meningitis in the mature PCV10\/13 period: findings from the PSERENADE project","volume":"9(4):738","author":"Garcia Quesada","year":"2021","journal-title":"Microorganisms"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126765_bb0135","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S1473-3099(20)30165-1","article-title":"Invasive pneumococcal disease incidence in children and adults in France during the pneumococcal conjugate vaccine era: an interrupted time-series analysis of data from a 17-year national prospective surveillance study","volume":"21","author":"Ouldali","year":"2021","journal-title":"Lancet Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25000623?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25000623?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T14:30:02Z","timestamp":1750861802000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25000623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":27,"alternative-id":["S0264410X25000623"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.126765","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Childhood invasive pneumococcal disease and acute otitis media in Central Greece during 2005-2024 \u2013 A report at the doorstep of the new multivalent PCV era","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.126765","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"126765"}}